
LENSAR LNSR
$ 6.11
3.21%
Annual report 2025
added 03-31-2026
LENSAR Interest Expense 2011-2026 | LNSR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense LENSAR
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 636 K | 660 K | 698 K | 263 K | 51 K | 1.34 M | 2 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2 M | 51 K | 807 K |
Quarterly Interest Expense LENSAR
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 133 K | 193 K | 159 K | - | 153 K | 160 K | 198 K | - | 265 K | 111 K | 89 K | - | 92 K | 39 K | 9 K | - | 10 K | 13 K | 18 K | - | 65 K | 671 K | 604 K | - | 494 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 671 K | 9 K | 183 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
7.68 M | $ 186.6 | 3.28 % | $ 14 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
AxoGen
AXGN
|
167 K | $ 34.49 | 3.05 % | $ 1.59 B | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.72 | 3.25 % | $ 1.72 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 292.85 | 1.62 % | $ 8.26 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.19 | -4.21 % | $ 119 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 40.45 | 3.57 % | $ 6.03 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 64.29 | 1.76 % | $ 95.2 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 10.37 | 3.6 % | $ 294 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
78 K | $ 25.33 | 1.52 % | $ 214 M | ||
|
Myomo
MYO
|
-668 K | $ 0.76 | 3.85 % | $ 31.8 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.45 | - | $ 172 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 95.85 | 3.09 % | $ 13 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.99 | -1.97 % | $ 1.21 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.43 | 3.62 % | $ 938 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.8 | 5.01 % | $ 418 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.78 | 3.16 % | $ 386 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 56.23 | 2.46 % | $ 1.65 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 39.57 | 2.89 % | $ 1.23 B | ||
|
LivaNova PLC
LIVN
|
664 K | $ 65.44 | 1.33 % | $ 3.57 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 89.11 | 1.57 % | $ 3.1 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.7 | -0.05 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 78.24 | 0.15 % | $ 45.8 B |